Visual imagery to highlight content on this page

BioSciCon Joins Campus Community

Biomedical Science Consulting, Inc., known as BioSciCon, is the newest on-site corporate partner at the Johns Hopkins University Montgomery County Campus.

BioSciCon is a woman-owned, biotechnology R&D, small business company focusing on the development of a proprietary platform MarkPap® technology for improving pap tests and creating more accurate early detection of cervical cancer and precancerosis. The MarkPap® technology is based on a unique biomarker discovered and patented by the owners in 2000.

BioSciCon is the R&D component of a four-company consortium: MarkPap LLC, a company with a mission to commercialize BioSciCon's products as they emerge from R&D; MarkPap Pacific LLC with a limited mission to promote MarkPap technology in India and China; and The Global Academy for Women's Health, Inc., an independent non-profit organization which integrates prior non-profit activities of BioSciCon's founders.

“We’re extremely pleased to be able to meet the needs of this small R&D company on our campus,” said Elaine Amir, Executive Director, Johns Hopkins Montgomery County. “We’ve been long planning to create an incubator or accelerator on our campus, and the addition of BioSciCon to our campus is a first step in doing so.”

BioSciCon was founded by Drs. Olivera and Nenad Markovic, co-authors of What Every Woman Should Know about Cervical Cancer (Springer).

Olivera Markovic, M.D., Ph.D., is an experienced, NIH trained cancer research scientist, university/medical school professor and author who has published more then 180 scientific publications, including books, chapters, invited review articles and patents. Nenad Markovic, M.D., Ph.D., is an internist, hematologist-oncologist, Professor Emeritus in oncology and author with more then 200 scientific publications, including books, chapters and patents.

CATEGORY: Research